封面
市場調查報告書
商品編碼
1764019

生物聚合物基底傷口敷料市場-全球產業規模、佔有率、趨勢、機會及預測(按類型、應用、最終用戶、地區和競爭細分,2020-2030 年)

Biopolymer Based Wound Dressing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Application, By End User, By Region and Competition, 2020-2030F

出版日期: | 出版商: TechSci Research | 英文 187 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球生物聚合物基傷口敷料市場價值為 3.4237 億美元,預計到 2030 年將達到 5.1239 億美元,預測期內的複合年成長率為 6.91%。隨著生物聚合物(天然或合成的聚合物)製成的傷口敷料的日益普及,這一細分市場在醫療產業中發展勢頭強勁。這些敷料因其與人體的兼容性、支持組織再生和環保特徵而備受青睞。隨著對先進傷口護理的需求不斷成長,生物聚合物基解決方案擴大用於治療慢性傷口、燒傷、手術切口和創傷。慢性病激增、人口老化以及全球對更佳傷口管理的重視是重要的成長因素。這些敷料具有控制感染、保濕和促進癒合等優勢,同時也能提高患者的舒適度。該市場的特點是持續創新、監管重點關注安全性和有效性,以及旨在加強市場地位和滿足現代傷口護理不斷變化的需求的策略合作夥伴關係。

市場概覽
預測期 2026-2030
2024年市場規模 3.4237億美元
2030年市場規模 5.1239億美元
2025-2030 年複合年成長率 6.91%
成長最快的領域 殼聚醣
最大的市場 北美洲

關鍵市場促進因素

慢性傷口盛行率上升

主要市場挑戰

有限的臨床證據

主要市場趨勢

個人化傷口護理解決方案

目錄

第 1 章:產品概述

第2章:研究方法

第3章:執行摘要

第4章:顧客之聲

第5章:臨床試驗分析

第6章:全球生物聚合物傷口敷料市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 依類型(甲殼素、殼聚醣、海藻酸鈉、海藻酸鈣、其他)
    • 依用途(燒傷、潰瘍、割傷、撕裂傷、其他)
    • 按最終使用者(醫院、門診手術中心、其他)
    • 按地區
    • 按公司分類(2024)
  • 產品地圖
  • 按類型
  • 按應用
  • 按最終用戶
  • 按地區

第7章:北美生物聚合物傷口敷料市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美:國家分析
    • 美國
    • 加拿大
    • 墨西哥

第8章:歐洲生物聚合物傷口敷料市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲:國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第9章:亞太地區生物聚合物傷口敷料市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區:國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第 10 章:南美洲生物聚合物傷口敷料市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲:國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第 11 章:中東和非洲生物聚合物傷口敷料市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA:國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 12 章:市場動態

  • 驅動程式
  • 挑戰

第13章:市場趨勢與發展

  • 近期發展
  • 併購
  • 產品發布

第 14 章:全球生物聚合物傷口敷料市場:SWOT 分析

第 15 章:波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 顧客的力量
  • 替代產品的威脅

第 16 章:競爭格局

  • HemCon Medical Technologies, Inc.
  • 3M Company
  • Integra LifeSciences Corporation
  • ConvaTec Group PLC
  • Smith & Nephew plc
  • Advancis Medical
  • Coloplast A/S
  • Lohmann & Rauscher GmbH & Co KG
  • Sorbsan
  • KiBou Pharma

第 17 章:策略建議

第18章調查會社について,免責事項

簡介目錄
Product Code: 15882

The Global Biopolymer Based Wound Dressing Market was valued at USD 342.37 million in 2024 and is projected to reach USD 512.39 million by 2030, growing at a CAGR of 6.91% during the forecast period. This market segment is gaining momentum within the medical industry due to the rising adoption of wound dressings made from biopolymers-polymers that are either naturally sourced or synthetically produced. These dressings are favored for their compatibility with the human body, support for tissue regeneration, and eco-friendly attributes. With growing demand for advanced wound care, biopolymer-based solutions are increasingly used to manage chronic wounds, burns, surgical incisions, and traumatic injuries. The surge in chronic diseases, aging populations, and the global emphasis on better wound management are significant growth factors. These dressings provide advantages such as infection control, moisture retention, and enhanced healing, all while improving patient comfort. The market is marked by continuous innovation, regulatory focus on safety and efficacy, and strategic partnerships aiming to strengthen market presence and meet the evolving needs of modern wound care.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 342.37 Million
Market Size 2030USD 512.39 Million
CAGR 2025-20306.91%
Fastest Growing SegmentChitosan
Largest MarketNorth America

Key Market Drivers

Rising Prevalence of Chronic Wounds

The growing number of chronic wounds is a major factor fueling the Global Biopolymer Based Wound Dressing Market. Conditions like diabetic foot ulcers, venous leg ulcers, and pressure sores present long-term healing challenges and often require specialized care. According to the International Diabetes Federation's 2024 report, nearly one in ten adults worldwide now lives with diabetes, significantly contributing to chronic wound prevalence. Addressing these wounds demands advanced and prolonged care approaches that improve healing outcomes and reduce complications. Biopolymer-based dressings, composed of materials like chitosan, alginate, and collagen, offer essential properties such as moisture balance and antibacterial effects. Clinical evidence, including a 2023 study in Advances in Wound Care, has shown that these dressings can shorten healing times for diabetic foot ulcers by over 30% compared to traditional options. Their ability to support tissue repair and manage infection makes them well-suited for treating chronic wounds effectively.

Key Market Challenges

Limited Clinical Evidence

A key challenge hindering the growth of the Global Biopolymer Based Wound Dressing Market is the limited availability of strong clinical evidence. While early research and anecdotal results suggest notable benefits, a lack of comprehensive clinical trials restricts the full endorsement of these products by healthcare professionals and regulatory authorities. Clinical validation is essential to confirm safety, performance, and cost-effectiveness, particularly in areas such as healing time, infection control, and patient comfort. However, producing this evidence involves significant investment, complex study designs, and coordination among manufacturers, researchers, and healthcare providers. Without large-scale, long-term studies, confidence in biopolymer-based wound dressings remains limited, delaying market expansion and broader adoption.

Key Market Trends

Personalized Wound Care Solutions

A leading trend in the Global Biopolymer Based Wound Dressing Market is the emergence of personalized wound care solutions tailored to individual patient needs. This approach recognizes that wounds differ in size, depth, exudate levels, and healing rates, and therefore require customized treatment strategies. Biopolymer-based dressings offer the flexibility to meet these needs by regulating moisture, enabling oxygen exchange, and incorporating targeted therapeutic agents. Advances in material science and manufacturing now allow for precise engineering of dressings to address specific wound profiles. Healthcare providers can select dressings based on patient-specific factors, enhancing healing efficiency and minimizing complications. This shift toward individualized wound management reflects a broader movement in healthcare toward patient-centric solutions.

Key Market Players

  • HemCon Medical Technologies, Inc.
  • 3M Company
  • Integra LifeSciences Corporation
  • ConvaTec Group PLC
  • Smith & Nephew plc
  • Advancis Medical
  • Coloplast A/S
  • Lohmann & Rauscher GmbH & Co KG
  • Sorbsan
  • KiBou Pharma

Report Scope:

In this report, the Global Biopolymer Based Wound Dressing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Biopolymer Based Wound Dressing Market, By Type:

  • Chitin
  • Chitosan
  • Sodium Alginate
  • Calcium Alginate
  • Others

Biopolymer Based Wound Dressing Market, By Application:

  • Burns
  • Ulcers
  • Cuts and Lacerations
  • Others

Biopolymer Based Wound Dressing Market, By End User:

  • Hospitals
  • Ambulatory Surgery Center
  • Others

Biopolymer Based Wound Dressing Market, By region:

  • North America
    • United States
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • India
    • South Korea
    • Australia
    • Japan
  • Europe
    • Germany
    • France
    • United Kingdom
    • Spain
    • Italy
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Biopolymer Based Wound Dressing Market.

Available Customizations:

Global Biopolymer Based Wound Dressing Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validations
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Clinical Trial Analysis

  • 5.1. Ongoing Clinical Trials
  • 5.2. Completed Clinical Trials
  • 5.3. Terminated Clinical Trials
  • 5.4. Breakdown of Pipeline, By Development Phase
  • 5.5. Breakdown of Pipeline, By Status
  • 5.6. Breakdown of Pipeline, By Study Type
  • 5.7. Breakdown of Pipeline, By Region
  • 5.8. Clinical Trials Heat Map

6. Global Biopolymer Based Wound Dressing Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type (Chitin, Chitosan, Sodium Alginate, Calcium Alginate, Others)
    • 6.2.2. By Application (Burns, Ulcers, Cuts and Lacerations, Others)
    • 6.2.3. By End User (Hospitals, Ambulatory Surgery Centers, Others)
    • 6.2.4. By Region
    • 6.2.5. By Company (2024)
  • 6.3. Product Map
  • 5.3.1 By Type
  • 5.3.2 By Application
  • 5.3.3 By End User
  • 5.3.4 By Region

7. North America Biopolymer Based Wound Dressing Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type (Chitin, Chitosan, Sodium Alginate, Calcium Alginate, Others)
    • 7.2.2. By Application (Burns, Ulcers, Cuts and Lacerations, Others)
    • 7.2.3. By End User (Hospitals, Ambulatory Surgery Centers, Others)
    • 7.2.4. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Biopolymer Based Wound Dressing Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End User
    • 7.3.2. Canada Biopolymer Based Wound Dressing Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End User
    • 7.3.3. Mexico Biopolymer Based Wound Dressing Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End User

8. Europe Biopolymer Based Wound Dressing Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type (Chitin, Chitosan, Sodium Alginate, Calcium Alginate, Others)
    • 8.2.2. By Application (Burns, Ulcers, Cuts and Lacerations, Others)
    • 8.2.3. By End User (Hospitals, Ambulatory Surgery Centers, Others)
    • 8.2.4. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Biopolymer Based Wound Dressing Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End User
    • 8.3.2. Germany Biopolymer Based Wound Dressing Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End User
    • 8.3.3. United Kingdom Biopolymer Based Wound Dressing Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End User
    • 8.3.4. Italy Biopolymer Based Wound Dressing Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End User
    • 8.3.5. Spain Biopolymer Based Wound Dressing Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End User

9. Asia-Pacific Biopolymer Based Wound Dressing Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type (Chitin, Chitosan, Sodium Alginate, Calcium Alginate, Others)
    • 9.2.2. By Application (Burns, Ulcers, Cuts and Lacerations, Others)
    • 9.2.3. By End User (Hospitals, Ambulatory Surgery Centers, Others)
    • 9.2.4. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China Biopolymer Based Wound Dressing Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End User
    • 9.3.2. India Biopolymer Based Wound Dressing Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End User
    • 9.3.3. Japan Biopolymer Based Wound Dressing Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End User
    • 9.3.4. South Korea Biopolymer Based Wound Dressing Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Type
        • 9.3.4.2.2. By Application
        • 9.3.4.2.3. By End User
    • 9.3.5. Australia Biopolymer Based Wound Dressing Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Type
        • 9.3.5.2.2. By Application
        • 9.3.5.2.3. By End User

10. South America Biopolymer Based Wound Dressing Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type (Chitin, Chitosan, Sodium Alginate, Calcium Alginate, Others)
    • 10.2.2. By Application (Burns, Ulcers, Cuts and Lacerations, Others)
    • 10.2.3. By End User (Hospitals, Ambulatory Surgery Centers, Others)
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Biopolymer Based Wound Dressing Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End User
    • 10.3.2. Argentina Biopolymer Based Wound Dressing Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End User
    • 10.3.3. Colombia Biopolymer Based Wound Dressing Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End User

11. Middle East and Africa Biopolymer Based Wound Dressing Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Type (Chitin, Chitosan, Sodium Alginate, Calcium Alginate, Others)
    • 11.2.2. By Application (Burns, Ulcers, Cuts and Lacerations, Others)
    • 11.2.3. By End User (Hospitals, Ambulatory Surgery Centers, Others)
    • 11.2.4. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Biopolymer Based Wound Dressing Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Type
        • 11.3.1.2.2. By Application
        • 11.3.1.2.3. By End User
    • 11.3.2. Saudi Arabia Biopolymer Based Wound Dressing Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Type
        • 11.3.2.2.2. By Application
        • 11.3.2.2.3. By End User
    • 11.3.3. UAE Biopolymer Based Wound Dressing Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Type
        • 11.3.3.2.2. By Application
        • 11.3.3.2.3. By End User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

  • 13.1. Recent Development
  • 13.2. Mergers & Acquisitions
  • 13.3. Product Launches

14. Global Biopolymer Based Wound Dressing Market: SWOT Analysis

15. Porter's Five Forces Analysis

  • 15.1. Competition in the Industry
  • 15.2. Potential of New Entrants
  • 15.3. Power of Suppliers
  • 15.4. Power of Customers
  • 15.5. Threat of Substitute Products

16. Competitive Landscape

  • 16.1. HemCon Medical Technologies, Inc.
    • 16.1.1. Business Overview
    • 16.1.2. Company Snapshot
    • 16.1.3. Products & Services
    • 16.1.4. Financials (As Reported)
    • 16.1.5. Recent Developments
    • 16.1.6. Key Personnel Details
    • 16.1.7. SWOT Analysis
  • 16.2. 3M Company
  • 16.3. Integra LifeSciences Corporation
  • 16.4. ConvaTec Group PLC
  • 16.5. Smith & Nephew plc
  • 16.6. Advancis Medical
  • 16.7. Coloplast A/S
  • 16.8. Lohmann & Rauscher GmbH & Co KG
  • 16.9. Sorbsan
  • 16.10. KiBou Pharma

17. Strategic Recommendations

18. About Us & Disclaimer